Article Text

Download PDFPDF
Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
  1. A. Politi,
  2. M. Sticca,
  3. M. Galli
  1. Department of Cardiology, S Anna Hospital, Como, Italy.


    Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.